Fosaprepitant Dimeglumine

Records for this ingredient, by country (identity only).

ATC A04AD · 5 markets · 43 records

Fosaprepitant Dimeglumine 5 markets · 43 records Forms
Filters

US 27 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

  • 150 mg/5 mLinjectionEMENDFOSAPREPITANT、NAVITRUX、Manufacturer: BE Pharmaceuticals Inc.、Manufacturer: BluePoint Laboratories、Manufacturer: Bryant Ranch Prepack、Manufacturer: Dr. Reddy's Laboratories In…、Manufacturer: Eugia US LLC、Manufacturer: Fresenius Kabi USA, LLC +5
  • 150 mg per mL / per unit basis not statedinjectionManufacturer: Actavis Pharma, Inc.Manufacturer: Dr. Reddy's Laboratories In…
  • 150 mg/50 mLinjectionFOCINVEZ

AU 8 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 245.3 mg per mL / per unit basis not statedinjectionFOSAPREPITANT JUNO fosaprepitant (as dimeglumine) 150 mg powder for injection vialFOSAPREPITANT MEDICIANZ fosaprepitant (as dimeglumine) 150 mg powder for injection vial、FOSAPREPITANT MEDSURGE fosaprepitant (as dimeglumine) 150 mg powder for injection vial、FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial、FOSAPREPITANT-AFT fosaprepitant (as dimeglumine) 150 mg powder for injection vial unknown
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名FOSAPREPITANT MEDSURGE ×1FOSAPREPITANT MSN ×1FOSAPREPITANT-AFT ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 3 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 3 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 150 mg per mL / per unit basis not statedinjectionEmend® I.V. Powder for Solution for Infusion 150mg
  • 150 mg/vial per mL / per unit basis not statedinjectionAPRITANT IV powder for solution for injection 150mg/vialFOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.